Moolec Science S.A.(MLEC)

Biotechnology · Grand Cayman, GT

$4.83-0.04 (-0.72%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T21:02:35.784Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:02:35.784Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 3,503,519
Total debt · period ending 2025-12-31: N/A
Cash · period ending 2025-12-31: N/A
TTM operating EBITDA · period ending 2024-12-31: N/A

FMP input reference: fadf2323dc19255bcc42afaef1a50e536e77fb7c46cec045ed2d3efdc7ae0f8f

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

MLEC EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

MLEC Competitors' EV/EBITDA Ratio

MLEC

Moolec Science S.A.

Current

Market Cap

$3.50M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EOCN

Eocene Ltd.

vs MLEC

Market Cap

$3.50M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBIO

Mustang Bio, Inc.

vs MLEC

Market Cap

$3.49M

EV/EBITDA Ratio

N/A

TTM Avg

1128.55x

3Y Avg

1128.55x

5Y Avg

1128.55x

CVKD

Cadrenal Therapeutics, Inc. Common Stock

vs MLEC

Market Cap

$3.53M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

WOK

WORK Medical Technology Group Ltd. Class A

vs MLEC

Market Cap

$3.63M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ERNA

Ernexa Therapeutics Inc.

vs MLEC

Market Cap

$3.65M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EVGN

Evogene Ltd.

vs MLEC

Market Cap

$3.65M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NXL

Nexalin Technology, Inc.

vs MLEC

Market Cap

$3.30M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PAVS

Paranovus Entertainment Technology Ltd.

vs MLEC

Market Cap

$3.28M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBAI

MBody AI Ltd.

vs MLEC

Market Cap

$3.25M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Moolec Science S.A. (MLEC)	$3.50M	N/A	N/A	N/A	N/A
Eocene Ltd. (EOCN)vs ›	$3.50M	N/A	N/A	N/A	N/A
Mustang Bio, Inc. (MBIO)vs ›	$3.49M	N/A	1128.55x	1128.55x	1128.55x
Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs ›	$3.53M	N/A	N/A	N/A	N/A
WORK Medical Technology Group Ltd. Class A (WOK)vs ›	$3.63M	N/A	N/A	N/A	N/A
Ernexa Therapeutics Inc. (ERNA)vs ›	$3.65M	N/A	N/A	N/A	N/A
Evogene Ltd. (EVGN)vs ›	$3.65M	N/A	N/A	N/A	N/A
Nexalin Technology, Inc. (NXL)vs ›	$3.30M	N/A	N/A	N/A	N/A
Paranovus Entertainment Technology Ltd. (PAVS)vs ›	$3.28M	N/A	N/A	N/A	N/A
MBody AI Ltd. (MBAI)vs ›	$3.25M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics